123 related articles for article (PubMed ID: 24038963)
1. Flow cytometric quantification of intraperitoneal free tumor cells (FTC) in patients with peritoneal metastasis.
Kitayama J; Emoto S; Yamaguchi H; Ishigami H; Kamei T; Yamashita H; Seto Y; Matsuzaki K; Watanabe T
Cytometry B Clin Cytom; 2013 Aug; ():. PubMed ID: 24038963
[TBL] [Abstract][Full Text] [Related]
2. Flow cytometric quantification of intraperitoneal free tumor cells in patients with peritoneal metastasis.
Kitayama J; Emoto S; Yamaguchi H; Ishigami H; Kamei T; Yamashita H; Seto Y; Matsuzaki K; Watanabe T
Cytometry B Clin Cytom; 2014 Jan; 86(1):56-62. PubMed ID: 24115348
[TBL] [Abstract][Full Text] [Related]
3. Flow Cytometric Quantification of Intraperitoneal Free Tumor Cells is a Useful Biomarker in Gastric Cancer Patients with Peritoneal Metastasis.
Kitayama J; Emoto S; Yamaguchi H; Ishigami H; Onoyama H; Yamashita H; Seto Y; Matsuzaki K; Watanabe T
Ann Surg Oncol; 2015 Jul; 22(7):2336-42. PubMed ID: 25404476
[TBL] [Abstract][Full Text] [Related]
4. Flow cytometry-based analysis of tumor-leukocyte ratios in peritoneal fluid from patients with advanced gastric cancer.
Takahashi K; Kurashina K; Saito S; Kanamaru R; Ohzawa H; Yamaguchi H; Miyato H; Hosoya Y; Lefor AK; Sata N; Kitayama J
Cytometry B Clin Cytom; 2021 Nov; 100(6):666-675. PubMed ID: 33277773
[TBL] [Abstract][Full Text] [Related]
5. Altered intraperitoneal immune microenvironment in patients with peritoneal metastases from gastric cancer.
Takahashi K; Kurashina K; Yamaguchi H; Kanamaru R; Ohzawa H; Miyato H; Saito S; Hosoya Y; Lefor AK; Sata N; Kitayama J
Front Immunol; 2022; 13():969468. PubMed ID: 36119051
[TBL] [Abstract][Full Text] [Related]
6. [Laparoscopic peritoneal dialysis catheter implantation in peritoneal chemotherapy for gastric cancer with peritoneal metastasis].
Ma JJ; Zang L; Yang ZY; Xie BW; Hong XZ; Cai ZH; Zhang LY; Yan C; Zhu ZG; Zheng MH
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Aug; 22(8):774-780. PubMed ID: 31422617
[No Abstract] [Full Text] [Related]
7. [Application of laparoscopic exploration combined with abdominal exfoliative cytology in the diagnosis and treatment of locally advanced gastric cancer].
Ding PA; Liu Y; Guo HH; Yang PG; Tian Y; Fan LQ; Tan BB; Li Y; Zhao Q
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Feb; 23(2):170-176. PubMed ID: 32074798
[No Abstract] [Full Text] [Related]
8. Surgery with hyperthermic intraperitoneal chemotherapy after response to induction chemotherapy in patients with peritoneal metastasis of gastric cancer.
Canbay E; Canbay Torun B; Cosarcan K; Altunal C; Gurbuz B; Bilgic C; Sezgin C; Kaban KK; Yilmaz S; Yazici Z
J Gastrointest Oncol; 2021 Apr; 12(Suppl 1):S47-S56. PubMed ID: 33968425
[TBL] [Abstract][Full Text] [Related]
9. Detection of free intraperitoneal tumour cells in peritoneal lavage fluid from patients with peritoneal metastasis before and after treatment with pressurised intraperitoneal aerosol chemotherapy (PIPAC).
Graversen M; Fristrup C; Kristensen TK; Larsen TR; Pfeiffer P; Mortensen MB; Detlefsen S
J Clin Pathol; 2019 May; 72(5):368-372. PubMed ID: 30755498
[TBL] [Abstract][Full Text] [Related]
10. Cell-free and concentrated ascites reinfusion therapy (CART) for management of massive malignant ascites in gastric cancer patients with peritoneal metastasis treated with intravenous and intraperitoneal paclitaxel with oral S-1.
Yamaguchi H; Kitayama J; Emoto S; Ishigami H; Ito T; Hanafusa N; Watanabe T
Eur J Surg Oncol; 2015 Jul; 41(7):875-80. PubMed ID: 25986856
[TBL] [Abstract][Full Text] [Related]
11. Gastric cancer with positive peritoneal cytology: survival benefit after induction chemotherapy and conversion to negative peritoneal cytology.
Valletti M; Eshmuminov D; Gnecco N; Gutschow CA; Schneider PM; Lehmann K
World J Surg Oncol; 2021 Aug; 19(1):245. PubMed ID: 34404403
[TBL] [Abstract][Full Text] [Related]
12. Successful treatment of peritoneal recurrence after gastric cancer surgery with intravenous and intraperitoneal paclitaxel combined with S-1 chemotherapy: a case report.
Miyatani K; Miyauchi W; Kono Y; Shishido Y; Watanabe J; Hanaki T; Kihara K; Matsunaga T; Yamamoto M; Fukumoto Y; Tokuyasu N; Takano S; Sakamoto T; Honjo S; Hasegawa T; Fujiwara Y
Surg Case Rep; 2020 May; 6(1):88. PubMed ID: 32358679
[TBL] [Abstract][Full Text] [Related]
13. Multicenter Retrospective Analysis of Intraperitoneal Paclitaxel and Systemic Chemotherapy for Advanced Gastric Cancer with Peritoneal Metastasis.
Kim DW; Jee YS; Kim CH; Kim JJ; Park S; Choi SI; Park JM; Kim JH;
J Gastric Cancer; 2020 Mar; 20(1):50-59. PubMed ID: 32269844
[TBL] [Abstract][Full Text] [Related]
14. [Laparoscopic diagnosis of postoperative recurrence of peritoneal metastasis in gastric cancer patients and the clinical efficacy of bidirectional intraperitoneal and systemic chemotherapy].
Yan C; Yang ZY; Shi M; Xu W; Ni ZT; Hua ZC; Liu WT; Zhu ZL; Bi RD; Zheng YN; Feng RH; Yao XX; Chen MM; Li C; Zhang J; Yan M; Zhu ZG
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 May; 23(5):492-498. PubMed ID: 32842430
[No Abstract] [Full Text] [Related]
15. Separation and single-cell analysis for free gastric cancer cells in ascites and peritoneal lavages based on microfluidic chips.
Zhao J; Han Z; Xu C; Li L; Pei H; Song Y; Wang Z; Tang B
EBioMedicine; 2023 Apr; 90():104522. PubMed ID: 36933411
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of intraoperative intraperitoneal cytology for advanced gastric carcinoma.
Fujimoto T; Zhang B; Minami S; Wang X; Takahashi Y; Mai M
Oncology; 2002; 62(3):201-8. PubMed ID: 12065866
[TBL] [Abstract][Full Text] [Related]
17. Colonic stenosis caused by infection of an intraperitoneal access port system: a rare complication of intraperitoneal chemotherapy for gastric cancer with peritoneal metastasis.
Kinoshita J; Fushida S; Tsukada T; Oyama K; Watanabe T; Okamoto K; Makino I; Nakamura K; Hayashi H; Nakagawara H; Miyashita T; Tajima H; Takamura H; Ninomiya I; Kitagawa H; Fujimura T; Ohta T
World J Surg Oncol; 2014 Jun; 12():177. PubMed ID: 24893606
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of peritoneal lavage cytology and chemotherapy during surgery for advanced gastric cancer.
Funami Y; Tokumoto N; Miyauchi H; Ochiai T; Kuga K
Int Surg; 1999; 84(3):220-4. PubMed ID: 10533780
[TBL] [Abstract][Full Text] [Related]
19. Exosomal hsa-let-7g-3p and hsa-miR-10395-3p derived from peritoneal lavage predict peritoneal metastasis and the efficacy of neoadjuvant intraperitoneal and systemic chemotherapy in patients with gastric cancer.
Luo J; Jiang L; He C; Shi M; Yang ZY; Shi M; Lu S; Li C; Zhang J; Yan M; Zhu ZG; Yan C
Gastric Cancer; 2023 May; 26(3):364-378. PubMed ID: 36738390
[TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of bidirectional chemotherapy for treatment of patients with peritoneal dissemination from gastric cancer: Selection for cytoreductive surgery.
Yonemura Y; Endou Y; Shinbo M; Sasaki T; Hirano M; Mizumoto A; Matsuda T; Takao N; Ichinose M; Mizuno M; Miura M; Ikeda M; Ikeda S; Nakajima G; Yonemura J; Yuuba T; Masuda S; Kimura H; Matsuki N
J Surg Oncol; 2009 Sep; 100(4):311-6. PubMed ID: 19697437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
